Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.
D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone; D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000187:drug effects; D005260:Female; D006659:Histoplasmin; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006968:Hypersensitivity, Delayed; D007109:Immunity / Q000187:drug effects*; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D009109:Mumps virus / Q000276:immunology; D009578:Nitrobenzenes; D010902:Pituitary Gland; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D012882:Skin Tests; D014373:Tuberculin
D009578:Nitrobenzenes; D014373:Tuberculin; D000324:Adrenocorticotropic Hormone; D006659:Histoplasmin; D011241:Prednisone; D006854:Hydrocortisone